|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Apoptosis
|
 |
|
Title:
|
 |
Key contacts promote recongnito of baff-r by traf3
|
|
Structure:
|
 |
Tnf receptor-associated factor 3. Chain: a. Fragment: traf domain. Synonym: cd40 receptor-associated factor 1, craf1, cd40-bin protein, cd40bp, lmp1-associated protein, lap1, cap-1. Engineered: yes. Tumor necrosis factor receptor superfamily member chain: b. Fragment: residues 160-183.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: traf3, cap1, craf1. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Other_details: the sequence of this protein naturally exist sapiens (human).
|
|
Biol. unit:
|
 |
Hexamer (from PDB file)
|
|
Resolution:
|
 |
|
2.70Å
|
R-factor:
|
0.220
|
R-free:
|
0.260
|
|
|
Authors:
|
 |
K.R.Ely
|
|
Key ref:
|
 |
C.Z.Ni
et al.
(2004).
Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation.
J Immunol,
173,
7394-7400.
PubMed id:
Ref:
|
 |
|
Date:
|
 |
|
03-Apr-06
|
Release date:
|
11-Apr-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
protein binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Immunol
173:7394-7400
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation.
|
|
C.Z.Ni,
G.Oganesyan,
K.Welsh,
X.Zhu,
J.C.Reed,
A.C.Satterthwait,
G.Cheng,
K.R.Ely.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
B cell-activating factor belonging to the TNF family receptor (BAFF-R), a member
of the TNFR superfamily, plays a role in autoimmunity after ligation with BAFF
ligand (also called TALL-1, BLyS, THANK, or zTNF4). BAFF/BAFF-R interactions are
critical for B cell regulation, and signaling from this ligand-receptor complex
results in NF-kappaB activation. Most TNFRs transmit signals intracellularly by
recruitment of adaptor proteins called TNFR-associated factors (TRAFs). However,
BAFF-R binds only one TRAF adaptor, TRAF3, and this interaction negatively
regulates activation of NF-kappaB. In this study, we report the crystal
structure of a 24-residue fragment of the cytoplasmic portion of BAFF-R bound in
complex with TRAF3. The recognition motif (162)PVPAT(166) in BAFF-R is
accommodated in the same binding crevice on TRAF3 that binds two related TNFRs,
CD40 and LTbetaR, but is presented in a completely different structural
framework. This region of BAFF-R assumes an open conformation with two extended
strands opposed at right angles that each make contacts with TRAF3. The
recognition motif is located in the N-terminal arm and intermolecular contacts
mediate TRAF recognition. In the C-terminal arm, key stabilizing contacts are
made, including critical hydrogen bonds with Gln(379) in TRAF3 that define the
molecular basis for selective binding of BAFF-R solely to this member of the
TRAF family. A dynamic conformational adjustment of Tyr(377) in TRAF3 occurs
forming a new intermolecular contact with BAFF-R that stabilizes the complex.
The structure of the complex provides a molecular explanation for binding
affinities and selective protein interactions in TNFR-TRAF interactions.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Silke,
and
R.Brink
(2010).
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs.
|
| |
Cell Death Differ, 17,
35-45.
|
 |
|
|
|
|
 |
K.Z.Wang,
D.L.Galson,
and
P.E.Auron
(2010).
TRAF6 is autoinhibited by an intramolecular interaction which is counteracted by trans-ubiquitination.
|
| |
J Cell Biochem, 110,
763-771.
|
 |
|
|
|
|
 |
L.M.Staudt
(2010).
Oncogenic activation of NF-kappaB.
|
| |
Cold Spring Harb Perspect Biol, 2,
a000109.
|
 |
|
|
|
|
 |
C.G.Mayne,
F.E.Nashold,
Y.Sasaki,
and
C.E.Hayes
(2009).
Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice.
|
| |
Eur J Immunol, 39,
589-599.
|
 |
|
|
|
|
 |
C.G.Mayne,
I.J.Amanna,
and
C.E.Hayes
(2009).
Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival.
|
| |
Mol Immunol, 47,
590-599.
|
 |
|
|
|
|
 |
E.Braggio,
J.J.Keats,
X.Leleu,
S.Van Wier,
V.H.Jimenez-Zepeda,
R.Valdez,
R.F.Schop,
T.Price-Troska,
K.Henderson,
A.Sacco,
F.Azab,
P.Greipp,
M.Gertz,
S.Hayman,
S.V.Rajkumar,
J.Carpten,
M.Chesi,
M.Barrett,
A.K.Stewart,
A.Dogan,
P.L.Bergsagel,
I.M.Ghobrial,
and
R.Fonseca
(2009).
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
|
| |
Cancer Res, 69,
3579-3588.
|
 |
|
|
|
|
 |
J.F.Treml,
Y.Hao,
J.E.Stadanlick,
and
M.P.Cancro
(2009).
The BLyS family: toward a molecular understanding of B cell homeostasis.
|
| |
Cell Biochem Biophys, 53,
1.
|
 |
|
|
|
|
 |
M.P.Cancro,
D.P.D'Cruz,
and
M.A.Khamashta
(2009).
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.
|
| |
J Clin Invest, 119,
1066-1073.
|
 |
|
|
|
|
 |
P.Nakhaei,
T.Mesplede,
M.Solis,
Q.Sun,
T.Zhao,
L.Yang,
T.H.Chuang,
C.F.Ware,
R.Lin,
and
J.Hiscott
(2009).
The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.
|
| |
PLoS Pathog, 5,
e1000650.
|
 |
|
|
|
|
 |
C.G.Mayne,
I.J.Amanna,
F.E.Nashold,
and
C.E.Hayes
(2008).
Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice.
|
| |
Eur J Immunol, 38,
587-598.
|
 |
|
|
|
|
 |
L.S.Treml,
W.J.Quinn,
J.F.Treml,
J.L.Scholz,
and
M.P.Cancro
(2008).
Manipulating B cell homeostasis: a key component in the advancement of targeted strategies.
|
| |
Arch Immunol Ther Exp (Warsz), 56,
153-164.
|
 |
|
|
|
|
 |
C.M.Annunziata,
R.E.Davis,
Y.Demchenko,
W.Bellamy,
A.Gabrea,
F.Zhan,
G.Lenz,
I.Hanamura,
G.Wright,
W.Xiao,
S.Dave,
E.M.Hurt,
B.Tan,
H.Zhao,
O.Stephens,
M.Santra,
D.R.Williams,
L.Dang,
B.Barlogie,
J.D.Shaughnessy,
W.M.Kuehl,
and
L.M.Staudt
(2007).
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
|
| |
Cancer Cell, 12,
115-130.
|
 |
|
|
|
|
 |
E.Castigli,
and
R.S.Geha
(2007).
TACI, isotype switching, CVID and IgAD.
|
| |
Immunol Res, 38,
102-111.
|
 |
|
|
|
|
 |
E.Castigli,
S.A.Wilson,
A.Elkhal,
E.Ozcan,
L.Garibyan,
and
R.S.Geha
(2007).
Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
|
| |
J Allergy Clin Immunol, 120,
885-891.
|
 |
|
|
|
|
 |
I.Debnath,
K.M.Roundy,
J.J.Weis,
and
J.H.Weis
(2007).
Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
|
| |
Mol Immunol, 44,
2388-2399.
|
 |
|
|
|
|
 |
A.P.Sutherland,
F.Mackay,
and
C.R.Mackay
(2006).
Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.
|
| |
Pharmacol Ther, 112,
774-786.
|
 |
|
|
|
|
 |
C.Bossen,
and
P.Schneider
(2006).
BAFF, APRIL and their receptors: structure, function and signaling.
|
| |
Semin Immunol, 18,
263-275.
|
 |
|
|
|
|
 |
R.T.Woodland,
M.R.Schmidt,
and
C.B.Thompson
(2006).
BLyS and B cell homeostasis.
|
| |
Semin Immunol, 18,
318-326.
|
 |
|
|
|
|
 |
S.Haiat,
C.Billard,
C.Quiney,
F.Ajchenbaum-Cymbalista,
and
J.P.Kolb
(2006).
Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
|
| |
Immunology, 118,
281-292.
|
 |
|
|
|
|
 |
S.J.Killedar,
S.Y.Killedar,
S.E.Eckenrode,
R.A.McIndoe,
J.X.She,
C.Q.Nguyen,
A.B.Peck,
S.R.Cha,
and
S.Cha
(2006).
Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.
|
| |
Lab Invest, 86,
1243-1260.
|
 |
|
|
|
|
 |
S.K.Saha,
E.M.Pietras,
J.Q.He,
J.R.Kang,
S.Y.Liu,
G.Oganesyan,
A.Shahangian,
B.Zarnegar,
T.L.Shiba,
Y.Wang,
and
G.Cheng
(2006).
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.
|
| |
EMBO J, 25,
3257-3263.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|